Breaking News Instant updates and real-time market news.

ABBV

AbbVie

$110.81 /

+1.78 (+1.63%)

, ABC

AmerisourceBergen

$121.16 /

+0.69 (+0.57%)

04:55
04/22/21
04/22
04:55
04/22/21
04:55

American Academy of Neurology to hold a virtual meeting

73rd Annual Virtual Meeting of AAN will be held on April 17-22. Webcast Link

ABBV

AbbVie

$110.81 /

+1.78 (+1.63%)

ABC

AmerisourceBergen

$121.16 /

+0.69 (+0.57%)

ABT

Abbott

$122.61 /

+2.62 (+2.18%)

ACAD

Acadia Pharmaceuticals

$21.46 /

+0.67 (+3.22%)

ALNY

Alnylam

$137.67 /

+2 (+1.47%)

BIIB

Biogen

$269.13 /

-3.84 (-1.41%)

BMY

Bristol-Myers

$66.32 /

+0.265 (+0.40%)

BHVN

Biohaven Pharmaceutical

$75.13 /

+1.5 (+2.04%)

CPRX

Catalyst Pharmaceuticals

$4.52 /

+0.13 (+2.96%)

DGX

Quest Diagnostics

$130.08 /

+0.79 (+0.61%)

DNA

Ginkgo Bioworks

$94.97 /

+ (+0.00%)

HZNP

Horizon Therapeutics

$93.52 /

+2.45 (+2.69%)

LIVN

LivaNova

$83.05 /

+1.63 (+2.00%)

LLY

Eli Lilly

$191.00 /

+0.45 (+0.24%)

MDT

Medtronic

$130.19 /

+1.9 (+1.48%)

NVS

Novartis

$88.67 /

+0.84 (+0.96%)

NVTA

Invitae

$36.05 /

+1.795 (+5.24%)

PFE

Pfizer

$39.53 /

+0.5 (+1.28%)

PTCT

PTC Therapeutics

$45.78 /

-0.545 (-1.18%)

RETA

Reata Pharmaceuticals

$90.75 /

+1.17 (+1.31%)

SNY

Sanofi

$52.43 /

+0.44 (+0.85%)

SUPN

Supernus

$31.37 /

+0.61 (+1.98%)

TAK

Takeda Pharmaceutical

$16.93 /

+0.095 (+0.56%)

TEVA

Teva

$10.25 /

+0.135 (+1.33%)

TGTX

TG Therapeutics

$40.61 /

+0.64 (+1.60%)

ZGNX

Zogenix

$18.95 /

+0.09 (+0.48%)

AVDL

Avadel Pharmaceuticals

$8.46 /

+0.265 (+3.24%)

JNJ

Johnson & Johnson

$166.61 /

+0.16 (+0.10%)

  • 22

    Apr

  • 22

    Apr

  • 22

    Apr

  • 22

    Apr

  • 23

    Apr

  • 23

    Apr

  • 27

    Apr

  • 28

    Apr

  • 28

    Apr

  • 28

    Apr

  • 29

    Apr

  • 29

    Apr

  • 29

    Apr

  • 30

    Apr

  • 03

    May

  • 04

    May

  • 04

    May

  • 04

    May

  • 04

    May

  • 05

    May

  • 05

    May

  • 05

    May

  • 06

    May

  • 07

    May

  • 18

    May

  • 18

    May

  • 20

    May

  • 21

    May

  • 24

    May

  • 25

    May

  • 27

    May

  • 30

    May

  • 02

    Jun

  • 07

    Jun

  • 15

    Jun

  • 21

    Jul

  • 15

    Oct

  • 29

    Dec

  • 28

    Jan

  • 29

    Apr

  • 15

    May

  • 07

    Aug

  • 02

    Dec

  • 15

    Dec

  • 22

    Jan

  • 16

    Mar

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/21/21 Citi
Citi opens '90-day positive catalyst' on AbbVie, reiterates Buy rating
04/06/21 RBC Capital
AbbVie transferred with an Outperform at RBC Capital
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
ABC AmerisourceBergen
$121.16 /

+0.69 (+0.57%)

03/09/21 Baird
AmerisourceBergen remains top pick following results, says Baird
02/09/21 Mizuho
AmerisourceBergen price target raised to $114 from $104 at Mizuho
02/08/21 Cowen
AmerisourceBergen price target raised to $150 from $145 at Cowen
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI
ABT Abbott
$122.61 /

+2.62 (+2.18%)

04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
03/10/21 Wells Fargo
Wells says Quidel Covid testing comments not a direct read through to Abbott
ACAD Acadia Pharmaceuticals
$21.46 /

+0.67 (+3.22%)

04/07/21 Needham
Acadia price target lowered to $30 from $44 at Needham
04/07/21 H.C. Wainwright
Acadia downgraded to Neutral from Buy at H.C. Wainwright
04/06/21 SVB Leerink
Acadia price target lowered to $31 from $63 at SVB Leerink
04/06/21 Jefferies
Acadia downgraded to Hold at Jefferies after dementia-related psychosis CRL
ALNY Alnylam
$137.67 /

+2 (+1.47%)

02/22/21 Guggenheim
Alnylam downgraded to Neutral from Buy at Guggenheim
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 Barclays
Alnylam price target raised to $196 from $162 at Barclays
02/12/21 Citi
Alnylam downgraded to Neutral from Buy at Citi
BIIB Biogen
$269.13 /

-3.84 (-1.41%)

04/19/21 Jefferies
Biogen 'may have best risk/reward among large caps' in 2021-23, says Jefferies
04/13/21 Roth Capital
Roth Capital sees Applied Genetic's XLRS licensing as vote of confidence
04/12/21 Oppenheimer
Sage Therapeutics data support 'enthusiasm' for SAGE-324 in ET, says Oppenheimer
04/12/21 Wedbush
Biogen price target raised to $245 from $236 at Wedbush
BMY Bristol-Myers
$66.32 /

+0.265 (+0.40%)

04/21/21 Citi
Citi opens '90-day catalyst watch' on Bristol-Myers, reiterates Buy
04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
BHVN Biohaven Pharmaceutical
$75.13 /

+1.5 (+2.04%)

04/01/21 Piper Sandler
Piper migraine survey bearish for Amgen, bullish for Biohaven
03/11/21
Fly Intel: Top five analyst initiations
03/11/21 UBS
Biohaven Pharmaceutical initiated with a Buy at UBS
03/02/21 Mizuho
Biohaven Pharmaceutical price target raised to $103 from $93 at Mizuho
CPRX Catalyst Pharmaceuticals
$4.52 /

+0.13 (+2.96%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
DGX Quest Diagnostics
$130.08 /

+0.79 (+0.61%)

03/12/21 Baird
Quest Diagnostics downgraded to Neutral from Outperform at Baird
01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
DNA Ginkgo Bioworks
$94.97 /

+ (+0.00%)

HZNP Horizon Therapeutics
$93.52 /

+2.45 (+2.69%)

03/25/21 Guggenheim
Horizon Therapeutics price target raised to $120 from $115 at Guggenheim
03/22/21
Fly Intel: Top five analyst initiations
03/22/21 Morgan Stanley
Horizon Therapeutics resumed with an Overweight at Morgan Stanley
03/18/21 Citi
Horizon Therapeutics price target raised to $120 from $116 at Citi
LIVN LivaNova
$83.05 /

+1.63 (+2.00%)

04/19/21 Piper Sandler
LivaNova HF enrollment milestone a key step toward approval, says Piper Sandler
04/13/21 Piper Sandler
LivaNova price target raised to $92 from $81 at Piper Sandler
03/03/21
Fly Intel: Top five analyst downgrades
03/03/21 Berenberg
Berenberg cuts LivaNova EPS forecasts on investments, downgrades to Hold
LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
MDT Medtronic
$130.19 /

+1.9 (+1.48%)

04/15/21 Atlantic Equities
Atlantic Equities starts Medtronic at Overweight
04/15/21 Atlantic Equities
Medtronic initiated with an Overweight at Atlantic Equities
04/05/21 Citi
Citi opens positive catalyst watches on four medical supply stocks
02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
NVS Novartis
$88.67 /

+0.84 (+0.96%)

04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
NVTA Invitae
$36.05 /

+1.795 (+5.24%)

04/05/21 Oppenheimer
Oppenheimer upgrades Invitae on valuation, sees potential high $50s stock
04/05/21 Oppenheimer
Invitae upgraded to Outperform from Perform at Oppenheimer
02/18/21 Ladenburg
Invitae upgraded to Buy with $58 price target at Ladenburg
02/18/21 Ladenburg
Invitae upgraded to Buy from Neutral at Ladenburg
PFE Pfizer
$39.53 /

+0.5 (+1.28%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
PTCT PTC Therapeutics
$45.78 /

-0.545 (-1.18%)

03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
RETA Reata Pharmaceuticals
$90.75 /

+1.17 (+1.31%)

11/25/20 Citi
Reata Pharmaceuticals price target lowered to $234 from $260 at Citi
11/10/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $220 from $169 at Cantor Fitzgerald
11/10/20 Citi
Reata Pharmaceuticals price target raised to $260 from $244 at Citi
08/11/20 Cantor Fitzgerald
Reata Pharmaceuticals price target lowered to $169 from $275 at Cantor Fitzgerald
SNY Sanofi
$52.43 /

+0.44 (+0.85%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
SUPN Supernus
$31.37 /

+0.61 (+1.98%)

04/13/21 Jefferies
Supernus upgraded to Buy after survey work at Jefferies
04/13/21 Jefferies
Supernus upgraded to Buy from Hold at Jefferies
02/03/21 Piper Sandler
Supernus price target raised to $35 from $30 at Piper Sandler
06/16/20 Piper Sandler
Supernus upgraded to Overweight from Neutral at Piper Sandler
TAK Takeda Pharmaceutical
$16.93 /

+0.095 (+0.56%)

04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
TEVA Teva
$10.25 /

+0.135 (+1.33%)

04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
12/21/20 Gabelli
Teva named 'Best Idea for 2021' at Gabelli
11/27/20 H.C. Wainwright
Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright
TGTX TG Therapeutics
$40.61 /

+0.64 (+1.60%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
ZGNX Zogenix
$18.95 /

+0.09 (+0.48%)

04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
04/06/21 Citi
Longboard Pharmaceuticals initiated with a Buy at Citi
02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
12/04/20 Mizuho
Zogenix collaboration step in right direction, says Mizuho
AVDL Avadel Pharmaceuticals
$8.46 /

+0.265 (+3.24%)

03/10/21 H.C. Wainwright
Avadel Pharmaceuticals price target raised to $17 from $15 at H.C. Wainwright
01/25/21 Craig-Hallum
Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum
08/28/20 Oppenheimer
Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer
08/28/20 SVB Leerink
Avadel selloff on Jazz competition worries overdone, says SVB Leerink
JNJ Johnson & Johnson
$166.61 /

+0.16 (+0.10%)

04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs

TODAY'S FREE FLY STORIES

On The Fly
Fly Intel: After-Hours Movers » 18:58
06/23/21
06/23
18:58
06/23/21
18:58
SCS

Steelcase

$14.49 /

+0.04 (+0.28%)

, RCUS

Arcus Biosciences

$23.40 /

+0.67 (+2.95%)

, FSP

Franklin Street

$5.27 /

-0.13 (-2.41%)

, KBH

KB Home

$43.35 /

+0.1 (+0.23%)

, CNXC

Concentrix

$157.11 /

+2.23 (+1.44%)

, FUL

H.B. Fuller

$65.62 /

-0.885 (-1.33%)

, PRTG

Portage Biotech

$35.28 /

+2.38 (+7.23%)

, BNL

Broadstone Net Lease

$24.08 /

+0.37 (+1.56%)

, TALO

Talos Energy

$18.60 /

+0.47 (+2.59%)

, BYND

Beyond Meat

$147.37 /

-0.47 (-0.32%)

Check out this evening's…

ShowHide Related Items >><<
SCS Steelcase
$14.49 /

+0.04 (+0.28%)

RCUS Arcus Biosciences
$23.40 /

+0.67 (+2.95%)

FSP Franklin Street
$5.27 /

-0.13 (-2.41%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

CNXC Concentrix
$157.11 /

+2.23 (+1.44%)

FUL H.B. Fuller
$65.62 /

-0.885 (-1.33%)

BNL Broadstone Net Lease
$24.08 /

+0.37 (+1.56%)

TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

BYND Beyond Meat
$147.37 /

-0.47 (-0.32%)

SCS Steelcase
$14.49 /

+0.04 (+0.28%)

05/11/21 Berenberg
Berenberg starts 'market leader' Steelcase at Buy
05/11/21 Berenberg
Steelcase initiated with a Buy at Berenberg
05/07/21 Benchmark
Benchmark upgrades Steelcase to Buy on signs of recovery in commercial furniture
05/07/21 Benchmark
Steelcase upgraded to Buy from Hold at Benchmark
RCUS Arcus Biosciences
$23.40 /

+0.67 (+2.95%)

02/25/21 Barclays
Arcus Biosciences price target raised to $45 from $40 at Barclays
02/25/21 Mizuho
Arcus Biosciences price target raised to $43 from $40 at Mizuho
01/20/21 Citi
Arcus Biosciences price target raised to $51 from $32 at Citi
01/19/21 Wedbush
Arcus Biosciences price target raised to $55 from $48 at Wedbush
FSP Franklin Street
$5.27 /

-0.13 (-2.41%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

06/15/21 Wedbush
Wedbush sees pullback in KB Home shares as buying opportunity
04/15/21 Wells Fargo
KB Home initiated with an Overweight at Wells Fargo
03/29/21 Argus
KB Home's new orders were 'stellar', says Argus
03/25/21 Keefe Bruyette
KB Home price target raised to $48 from $44 at Keefe Bruyette
CNXC Concentrix
$157.11 /

+2.23 (+1.44%)

06/15/21 Barrington
Concentrix initiated with an Outperform at Barrington
01/07/21 Cross Research
Concentrix initiated with a Buy at Cross Research
12/08/20 Stifel
Synnex downgraded to Hold from Buy at Stifel
12/07/20 BofA
Concentrix initiated with a Buy at BofA
FUL H.B. Fuller
$65.62 /

-0.885 (-1.33%)

03/29/21 Deutsche Bank
H.B. Fuller price target raised to $65 from $56 at Deutsche Bank
03/26/21 Baird
H.B. Fuller price target raised to $72 from $65 at Baird
01/27/21 Deutsche Bank
H.B. Fuller price target raised to $56 from $48 at Deutsche Bank
01/04/21 Baird
H.B. Fuller upgraded to Outperform, added to 2021 top picks at Baird
PRTG Portage Biotech
$35.28 /

+2.38 (+7.23%)

BNL Broadstone Net Lease
$24.08 /

+0.37 (+1.56%)

06/22/21 BTIG
Broadstone Net Lease price target raised to $27 from $21 at BTIG
06/17/21 Goldman Sachs
Broadstone Net Lease downgraded to Neutral from Buy at Goldman Sachs
06/15/21
Fly Intel: Top five analyst downgrades
06/15/21 JPMorgan
JPMorgan upgrades W.P. Carey on swap out of Broadstone
TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

06/08/21
Fly Intel: Top five analyst initiations
06/08/21 Citi
Talos Energy initiated with a Buy at Citi
05/03/21 Roth Capital
Talos Energy price target raised to $18 from $13 at Roth Capital
04/13/21 Stifel
BP discovery holds over 100MMboe of potential net to Talos interest, says Stifel
BYND Beyond Meat
$147.37 /

-0.47 (-0.32%)

16:11 Today JPMorgan
Beyond Meat breakfast sandwich discontinued at Dunkin', says JPMorgan
05/24/21
Fly Intel: Top five analyst upgrades
05/24/21 Bernstein
Beyond Meat upgraded to Outperform from Underperform at Bernstein
05/11/21 Barclays
Beyond Meat price target lowered to $90 from $100 at Barclays
SCS Steelcase
$14.49 /

+0.04 (+0.28%)

RCUS Arcus Biosciences
$23.40 /

+0.67 (+2.95%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

CNXC Concentrix
$157.11 /

+2.23 (+1.44%)

FUL H.B. Fuller
$65.62 /

-0.885 (-1.33%)

BNL Broadstone Net Lease
$24.08 /

+0.37 (+1.56%)

TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

BYND Beyond Meat
$147.37 /

-0.47 (-0.32%)

  • 24
    Jun
  • 24
    Jun
  • 24
    Jun
  • 09
    Dec
  • 17
    Sep
KBH KB Home
$43.35 /

+0.1 (+0.23%)

TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

BYND Beyond Meat
$147.37 /

-0.47 (-0.32%)

SCS Steelcase
$14.49 /

+0.04 (+0.28%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

FUL H.B. Fuller
$65.62 /

-0.885 (-1.33%)

TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

BYND Beyond Meat
$147.37 /

-0.47 (-0.32%)

SCS Steelcase
$14.49 /

+0.04 (+0.28%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

CNXC Concentrix
$157.11 /

+2.23 (+1.44%)

FUL H.B. Fuller
$65.62 /

-0.885 (-1.33%)

BYND Beyond Meat
$147.37 /

-0.47 (-0.32%)

Hot Stocks
IGC completes final cohort of Phase 1 trial on Alzheimer's patients » 18:54
06/23/21
06/23
18:54
06/23/21
18:54
IGC

India Globalization Capital

$1.46 /

-0.01 (-0.68%)

India Globalization…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IGC India Globalization Capital
$1.46 /

-0.01 (-0.68%)

IGC India Globalization Capital
$1.46 /

-0.01 (-0.68%)

03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
02/02/21 Craig-Hallum
Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum
01/29/21 Stifel
'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
IGC India Globalization Capital
$1.46 /

-0.01 (-0.68%)

IGC India Globalization Capital
$1.46 /

-0.01 (-0.68%)

IGC India Globalization Capital
$1.46 /

-0.01 (-0.68%)

Hot Stocks
Box CEO: We're executing a very effective strategy » 18:48
06/23/21
06/23
18:48
06/23/21
18:48
BOX

Box

$25.22 /

+0.02 (+0.08%)

In an interview on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BOX Box
$25.22 /

+0.02 (+0.08%)

BOX Box
$25.22 /

+0.02 (+0.08%)

04/09/21 DA Davidson
Box price target lowered to $22 from $25 at DA Davidson
04/09/21 William Blair
KKR investment 'strong vote of confidence' in Box, says William Blair
04/09/21 William Blair
KKR investment 'strong vote of confidence' in Box, says William Blair
03/23/21 KeyBanc
Box price target raised to $27 from $22 at KeyBanc
BOX Box
$25.22 /

+0.02 (+0.08%)

BOX Box
$25.22 /

+0.02 (+0.08%)

BOX Box
$25.22 /

+0.02 (+0.08%)

BOX Box
$25.22 /

+0.02 (+0.08%)

Hot Stocks
J.M. Smucker CEO sells 10K shares of common stock » 18:44
06/23/21
06/23
18:44
06/23/21
18:44
SJM

J.M. Smucker

$129.06 /

-1.42 (-1.09%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SJM J.M. Smucker
$129.06 /

-1.42 (-1.09%)

SJM J.M. Smucker
$129.06 /

-1.42 (-1.09%)

06/04/21 Stifel
J.M. Smucker price target raised to $135 from $125 at Stifel
06/04/21 Deutsche Bank
J.M. Smucker price target raised to $140 from $138 at Deutsche Bank
06/04/21 BofA
J.M. Smucker price target raised to $140 from $124 at BofA
05/20/21 Deutsche Bank
J.M. Smucker named 'Catalyst Call: Buy Idea' at Deutsche Bank
SJM J.M. Smucker
$129.06 /

-1.42 (-1.09%)

SJM J.M. Smucker
$129.06 /

-1.42 (-1.09%)

SJM J.M. Smucker
$129.06 /

-1.42 (-1.09%)

SJM J.M. Smucker
$129.06 /

-1.42 (-1.09%)

Upgrade
Magna upgraded to Buy from Neutral at Goldman Sachs » 18:42
06/23/21
06/23
18:42
06/23/21
18:42
MGA

Magna

$92.86 /

+0.24 (+0.26%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MGA Magna
$92.86 /

+0.24 (+0.26%)

MGA Magna
$92.86 /

+0.24 (+0.26%)

06/21/21 Edward Jones
Magna upgraded to Buy from Hold at Edward Jones
05/31/21 BMO Capital
Magna price target raised to $115 from $108 at BMO Capital
05/10/21 Credit Suisse
Magna price target raised to $120 from $115 at Credit Suisse
04/20/21 Morgan Stanley
Fisker remains 'top ranked' EV related SPAC startup, says Morgan Stanley
MGA Magna
$92.86 /

+0.24 (+0.26%)

MGA Magna
$92.86 /

+0.24 (+0.26%)

MGA Magna
$92.86 /

+0.24 (+0.26%)

MGA Magna
$92.86 /

+0.24 (+0.26%)

Recommendations
Patterson Companies price target lowered to $41 from $44 at Piper Sandler » 18:39
06/23/21
06/23
18:39
06/23/21
18:39
PDCO

Patterson Companies

$30.95 /

-4.18 (-11.90%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PDCO Patterson Companies
$30.95 /

-4.18 (-11.90%)

PDCO Patterson Companies
$30.95 /

-4.18 (-11.90%)

08:42 Today Piper Sandler
Patterson earnings pullback a buying opportunity, says Piper Sandler
06/17/21
Fly Intel: Top five analyst upgrades
06/17/21 Piper Sandler
Patterson Companies upgraded to Overweight from Neutral at Piper Sandler
03/03/21 Piper Sandler
Piper stays Neutral Patterson despite execution due to 'lingering uncertainty'
PDCO Patterson Companies
$30.95 /

-4.18 (-11.90%)

PDCO Patterson Companies
$30.95 /

-4.18 (-11.90%)

Periodicals
BuzzFeed close to go-public deal with 890 5th Avenue Partners, WSJ reports » 18:11
06/23/21
06/23
18:11
06/23/21
18:11
ENFA

890 5th Avenue Partners

$9.79 /

-0.01 (-0.10%)

BuzzFeed is nearing a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENFA 890 5th Avenue Partners
$9.79 /

-0.01 (-0.10%)

ENFA 890 5th Avenue Partners
$9.79 /

-0.01 (-0.10%)

Syndicate
Doximity 23.3M share IPO priced at $26.00 » 18:05
06/23/21
06/23
18:05
06/23/21
18:05
DOCS

Doximity

/

+

The deal priced above the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 24
    Jun
Syndicate
Confluent 23M share IPO priced at $36.00 » 18:04
06/23/21
06/23
18:04
06/23/21
18:04
CFLT

Confluent

/

+

The deal priced above the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 24
    Jun
Syndicate
Portage Biotech files to sell common stock, no amount given » 17:50
06/23/21
06/23
17:50
06/23/21
17:50
PRTG

Portage Biotech

$35.28 /

+2.38 (+7.23%)

Cantor Fitzgerald and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 24
    Jun
Initiation
PayPal initiated with a Buy at DA Davidson » 17:49
06/23/21
06/23
17:49
06/23/21
17:49
PYPL

PayPal

$288.11 /

+1.22 (+0.43%)

DA Davidson initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PYPL PayPal
$288.11 /

+1.22 (+0.43%)

PYPL PayPal
$288.11 /

+1.22 (+0.43%)

12:16 Today Credit Suisse
PayPal pricing update raises confidence in five-year outlook, says Credit Suisse
06/21/21 BofA
PayPal's announced price increase already in guidance, says BofA
06/21/21 Barclays
PayPal price increase to bring 2022 earnings upside, says Barclays
05/07/21 BMO Capital
PayPal price target raised to $256 from $241 at BMO Capital
PYPL PayPal
$288.11 /

+1.22 (+0.43%)

PYPL PayPal
$288.11 /

+1.22 (+0.43%)

PYPL PayPal
$288.11 /

+1.22 (+0.43%)

PYPL PayPal
$288.11 /

+1.22 (+0.43%)

Initiation
Square initiated with a Buy at DA Davidson » 17:38
06/23/21
06/23
17:38
06/23/21
17:38
SQ

Square

$238.66 /

+2.68 (+1.14%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SQ Square
$238.66 /

+2.68 (+1.14%)

SQ Square
$238.66 /

+2.68 (+1.14%)

05/25/21 Baird
Square comps starting to get more difficult, says Baird
05/20/21 Tigress Financial
Square shares have close to 50% upside potential, says Tigress Financial
05/10/21 BMO Capital
Square price target raised to $269 from $237 at BMO Capital
05/07/21 JPMorgan
Square price target raised to $300 from $250 at JPMorgan
SQ Square
$238.66 /

+2.68 (+1.14%)

SQ Square
$238.66 /

+2.68 (+1.14%)

SQ Square
$238.66 /

+2.68 (+1.14%)

SQ Square
$238.66 /

+2.68 (+1.14%)

Conference/Events
G-III Apparel participates in a conference call with UBS » 17:38
06/23/21
06/23
17:38
06/23/21
17:38
GIII

G-III Apparel

$32.57 /

+0.53 (+1.65%)

Consumer Goods Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GIII G-III Apparel
$32.57 /

+0.53 (+1.65%)

GIII G-III Apparel
$32.57 /

+0.53 (+1.65%)

06/08/21 B. Riley
G-III Apparel price target raised to $41 from $39 at B. Riley
06/08/21 Barclays
G-III Apparel price target raised to $30 from $27 at Barclays
03/19/21 B. Riley Securities
G-III Apparel price target raised to $38 from $33 at B. Riley Securities
03/19/21 Barclays
G-III Apparel price target raised to $27 from $24 at Barclays
GIII G-III Apparel
$32.57 /

+0.53 (+1.65%)

GIII G-III Apparel
$32.57 /

+0.53 (+1.65%)

Conference/Events
UBS quantitative analyst to hold analyst/industry conference call » 17:35
06/23/21
06/23
17:35
06/23/21
17:35

Analysts provide Quant…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Artius Acquisition shareholders approve Origin Materials business combination » 17:35
06/23/21
06/23
17:35
06/23/21
17:35
ORGN

Origin Materials

/

+

, AACQ

Artius Acquisition

$9.67 /

+0.325 (+3.48%)

Artius Acquisition (AACQ)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORGN Origin Materials
/

+

AACQ Artius Acquisition
$9.67 /

+0.325 (+3.48%)

ORGN Origin Materials
/

+

AACQ Artius Acquisition
$9.67 /

+0.325 (+3.48%)

05/03/21 Craig-Hallum
Artius Acquisition initiated with a Buy at Craig-Hallum
AACQ Artius Acquisition
$9.67 /

+0.325 (+3.48%)

Hot Stocks
Casey's General Stores director Bridgewater sells almost $599K in company shares » 17:34
06/23/21
06/23
17:34
06/23/21
17:34
CASY

Casey's General Stores

$198.27 /

-0.51 (-0.26%)

Casey's General…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CASY Casey's General Stores
$198.27 /

-0.51 (-0.26%)

CASY Casey's General Stores
$198.27 /

-0.51 (-0.26%)

06/22/21
Fly Intel: Top five analyst downgrades
06/22/21 Goldman Sachs
Casey's General Stores downgraded to Neutral from Buy at Goldman Sachs
06/22/21 Goldman Sachs
Alimentation Couche-Tard upgraded to Buy from Neutral at Goldman Sachs
06/10/21 Stephens
Casey's General Stores price target lowered to $230 from $250 at Stephens
CASY Casey's General Stores
$198.27 /

-0.51 (-0.26%)

CASY Casey's General Stores
$198.27 /

-0.51 (-0.26%)

CASY Casey's General Stores
$198.27 /

-0.51 (-0.26%)

Conference/Events
FDA Oncologic Drugs Advisory Committee to hold Virtual Meeting » 17:32
06/23/21
06/23
17:32
06/23/21
17:32
INCY

Incyte

$85.11 /

+0.06 (+0.07%)

The Committee discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INCY Incyte
$85.11 /

+0.06 (+0.07%)

INCY Incyte
$85.11 /

+0.06 (+0.07%)

07:10 Today Benchmark
Incyte's retifanlimab does not seem likely to be approved, says Benchmark
02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
INCY Incyte
$85.11 /

+0.06 (+0.07%)

INCY Incyte
$85.11 /

+0.06 (+0.07%)

INCY Incyte
$85.11 /

+0.06 (+0.07%)

INCY Incyte
$85.11 /

+0.06 (+0.07%)

Hot Stocks
Granite wins $20M bike trail project in California » 17:31
06/23/21
06/23
17:31
06/23/21
17:31
GVA

Granite

$39.80 /

+0.295 (+0.75%)

Granite has been awarded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GVA Granite
$39.80 /

+0.295 (+0.75%)

GVA Granite
$39.80 /

+0.295 (+0.75%)

04/15/21 DA Davidson
Granite upgraded to Buy from Neutral at DA Davidson
04/15/21 DA Davidson
Granite upgraded to Buy from Neutral at DA Davidson
03/31/21 DA Davidson
Granite price target raised to $35 from $17 at DA Davidson
06/25/20 DA Davidson
Granite Construction price target lowered to $17 from $30 at DA Davidson
GVA Granite
$39.80 /

+0.295 (+0.75%)

GVA Granite
$39.80 /

+0.295 (+0.75%)

Hot Stocks
KB Home raises FY21 housing revenue view to $5.9B-$6.1B from $5.7B-$6.1B » 17:27
06/23/21
06/23
17:27
06/23/21
17:27
KBH

KB Home

$43.35 /

+0.1 (+0.23%)

Raises FY21 average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

06/15/21 Wedbush
Wedbush sees pullback in KB Home shares as buying opportunity
04/15/21 Wells Fargo
KB Home initiated with an Overweight at Wells Fargo
03/29/21 Argus
KB Home's new orders were 'stellar', says Argus
03/25/21 Keefe Bruyette
KB Home price target raised to $48 from $44 at Keefe Bruyette
KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

Hot Stocks
KB Home sees Q3 community count up 5%  17:27
06/23/21
06/23
17:27
06/23/21
17:27
KBH

KB Home

$43.35 /

+0.1 (+0.23%)

 
ShowHide Related Items >><<
KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

06/15/21 Wedbush
Wedbush sees pullback in KB Home shares as buying opportunity
04/15/21 Wells Fargo
KB Home initiated with an Overweight at Wells Fargo
03/29/21 Argus
KB Home's new orders were 'stellar', says Argus
03/25/21 Keefe Bruyette
KB Home price target raised to $48 from $44 at Keefe Bruyette
KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

Hot Stocks
KB Home sees Q3 housing revenue $1.5B-$1.58B » 17:24
06/23/21
06/23
17:24
06/23/21
17:24
KBH

KB Home

$43.35 /

+0.1 (+0.23%)

Sees Q3 average selling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

06/15/21 Wedbush
Wedbush sees pullback in KB Home shares as buying opportunity
04/15/21 Wells Fargo
KB Home initiated with an Overweight at Wells Fargo
03/29/21 Argus
KB Home's new orders were 'stellar', says Argus
03/25/21 Keefe Bruyette
KB Home price target raised to $48 from $44 at Keefe Bruyette
KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

Syndicate
NeuBase Therapeutics files to sell 308.6K shares of common stock for holders  17:22
06/23/21
06/23
17:22
06/23/21
17:22
NBSE

NeuBase Therapeutics

$5.05 /

+0.13 (+2.64%)

 
ShowHide Related Items >><<
NBSE NeuBase Therapeutics
$5.05 /

+0.13 (+2.64%)

NBSE NeuBase Therapeutics
$5.05 /

+0.13 (+2.64%)

06/01/21 H.C. Wainwright
NeuBase Therapeutics price target lowered to $15 from $18 at H.C. Wainwright
05/18/21 Chardan
NeuBase Therapeutics named a top pick for 2021 at Chardan
02/12/21 H.C. Wainwright
NeuBase Therapeutics price target raised to $18 from $15 at H.C. Wainwright
NBSE NeuBase Therapeutics
$5.05 /

+0.13 (+2.64%)

  • 22
    Apr
NBSE NeuBase Therapeutics
$5.05 /

+0.13 (+2.64%)

Downgrade
Pirelli downgraded to Sell from Neutral at Goldman Sachs » 17:15
06/23/21
06/23
17:15
06/23/21
17:15
PLLIF

Pirelli

$5.50 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLLIF Pirelli
$5.50 /

+ (+0.00%)

05/14/21 Morgan Stanley
Pirelli price target raised to EUR 4.90 from EUR 4.80 at Morgan Stanley
05/05/21 JPMorgan
Pirelli price target raised to EUR 4.40 from EUR 4 at JPMorgan
04/28/21 UBS
Pirelli price target raised to EUR 5 from EUR 4.50 at UBS
04/01/21 Stifel
Pirelli downgraded to Hold from Buy at Stifel
Initiation
Opco starts Oaktree Specialty Lending with an Outperform on 'strong' credit » 17:08
06/23/21
06/23
17:08
06/23/21
17:08
OCSL

Oaktree Specialty Lending

$6.74 /

+0.025 (+0.37%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OCSL Oaktree Specialty Lending
$6.74 /

+0.025 (+0.37%)

OCSL Oaktree Specialty Lending
$6.74 /

+0.025 (+0.37%)

16:23 Today Oppenheimer
Oaktree Specialty Lending initiated with an Outperform at Oppenheimer
03/05/21 Hovde Group
Oaktree Specialty Lending initiated with an Outperform at Hovde Group
OCSL Oaktree Specialty Lending
$6.74 /

+0.025 (+0.37%)

Conference/Events
Fulcrum Therapeutics to host conference call » 17:05
06/23/21
06/23
17:05
06/23/21
17:05
FULC

Fulcrum Therapeutics

$9.13 /

+0.25 (+2.82%)

Management discusses the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FULC Fulcrum Therapeutics
$9.13 /

+0.25 (+2.82%)

FULC Fulcrum Therapeutics
$9.13 /

+0.25 (+2.82%)

04/26/21 Credit Suisse
Fulcrum Therapeutics assumed with an Outperform at Credit Suisse
03/22/21 Credit Suisse
Fulcrum Therapeutics initiated with an Outperform at Credit Suisse
03/04/21 Piper Sandler
Fulcrum Therapeutics price target lowered to $20 from $22 at Piper Sandler
03/01/21 Stifel
Fulcrum Therapeutics initiated with a Buy at Stifel
FULC Fulcrum Therapeutics
$9.13 /

+0.25 (+2.82%)

  • 20
    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.